If your browser is not displaying images correctly, try clearing your cookies and cache to solve the problem.
Login and Registration
You are not logged into the OTL TechFinder web site. If you are already registered, please login. Otherwise, registration is free and entitles you to receive emails and correspondence about new technology releases.
Would you like to find out about other ways to engage with Stanford?
If so, please visit http://corporate.stanford.edu/.
S09-338 Increased IL-17F in Serum determines non-responsiveness to IFN-beta treatment in Multiple Sclerosis
The major limitation of Interferon-beta as a treatment for multiple sclerosis (MS) is that 30-50% of MS patients do not respond to treatment. In the clinical setting, it would be desirable to identify responders and non-responders prior to the initiation ... more information »
S14-028 Small molecules for broad spectrum treatment of hepatocellular carcinoma
Researchers in Prof. Samuel So’s laboratory have discovered broad-spectrum compounds with anti-tumor activity against hepatocellular carcinoma (HCC). These small molecules inhibit the CDC37/HSP90 complex which is known to regulate a wide array of protei... more information »
What is TechFinder?
By clicking the links above you can search the database for opportunities and submit requests
for additional information. TechFinder contains text and images. TechFinder is updated within
minutes of any changes made at Stanford's Office of Technology Licensing.